Bio-Europe Digital

25 October 2021 - 29 October 2021
Schedule a 1:1 partnering meeting with Quotient Sciences at the digital BIO-Europe Meeting from October 25-29, 2021. John McDermott, Quotient's Executive Drug Development Consultant, will be on hand to discuss your drug development needs and update you on our expanded capabilities that include drug substnace synthesis & manufacturing, bioanalysis and radiolabelling.

John has over 16+ years industry experience in roles in pharmaceutical sciences with Rhone Poulenc Rorer, Covance and Quotient Sciences, which he joined in 2001. He has been central to the development of Quotient's integrated pharmaceutical and clinical development programs, utilizing our ability to manufacture drug products in real-time in response to arising human data. John's responsibilities at Quotient Sciences include the design and implementation of integrated pharmaceutical and clinical development programs. In addition, John has a significant body of experience in scintigraphic imaging studies for oral and inhaled dosage forms, including the development and validation of radiolabelling methods.

To schedule a meeting with John at the event, email:

Event details: